Related Experiment Videos
Alpha-methyltryptophan as a therapeutic agent
1Department of Psychiatry, Faculty of Medicine, McGill University, Montreal, Quebec.
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|January 1, 1991
Summary
Alpha-methyltryptophan administration produces alpha-methylserotonin in the brain, acting as a serotonin substitute in tests. This suggests alpha-methyltryptophan could treat disorders linked to serotonin deficiency.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Serotonin (5-hydroxytryptamine) is a key neurotransmitter implicated in various physiological and behavioral processes.
- Deficiencies in serotonin are associated with several neurological and psychiatric disorders.
Purpose of the Study:
- To investigate the potential of alpha-methyltryptophan as a precursor to alpha-methylserotonin.
- To evaluate alpha-methylserotonin's functional and behavioral effects as a serotonin substitute.
- To explore the therapeutic implications of alpha-methyltryptophan for serotonin-deficient conditions.
Main Methods:
- Administration of alpha-methyltryptophan to experimental animals.
- Assessment of cerebral alpha-methylserotonin formation.
- Evaluation of alpha-methylserotonin in behavioral and functional tests.
- Analysis of indoleamine properties (storage, uptake, release) and receptor binding.
Main Results:
- Alpha-methyltryptophan administration successfully generated cerebral alpha-methylserotonin.
- Alpha-methylserotonin demonstrated substitution for serotonin in specific behavioral and functional assays.
- Results align with the similar physicochemical properties of alpha-methylserotonin and serotonin.
- Alpha-methylserotonin exhibits 5HT2-receptor agonist activity.
Conclusions:
- Alpha-methylserotonin effectively mimics serotonin's actions in certain contexts.
- Alpha-methyltryptophan shows promise as a prodrug for delivering alpha-methylserotonin.
- Alpha-methyltryptophan is a potential therapeutic candidate for disorders characterized by serotonin deficiency.